Search results for: 'nanoparticle pharma'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent technology advances across cell & gene therapies, immunotherapies, intelligent drug discovery approaches, automated biomanufacturing and microbiome sciences. The TOE also encompasses recent developments in proteomics, drug deliver...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. The TOE also comprises innovations across stem cell therapies and radiotherapies.The Life Science, Health & Wellness TOE will feature d...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides innovation insights across cell and gene therapy advances. The TOE also encompasses recent therapy developments for neuropsychiatric, rare, and infectious diseases. The research covers recent advances in vaccines and biomanufacturing platforms.The Life ...

This issue of the Nanotechnology Opportunity Engine profiles significant nanotechnology advancements for various industrial applications. The featured innovations include Ceramic-based Nanocoating Solutions for Surface Protection, Liquid-repellent Nanocoating Technology for Surface Protection, Seaweed-derived Nanocellulose for Multi-industry Usage,...

This issue of the Nanotechnology Opportunity Engine profiles significant advances in nanotechnology for various industrial applications. The featured innovations include Self-activating Nanocapsule-based Fire Suppression Technique, Carbon Nanotube Production from Industrial Carbon Emissions, Molecularly Engineered Multifunctional Nanoparticle Reage...

This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...

An increasing number of organizations are interested in harnessing the extraordinary properties of microscopic nanoparticle, which can enable a thread that is smaller than steel or smart phones to be flexible and cognitive re-creating existing products with enhanced features. With every object and species in the surroundings made up of atoms and ...

20 Nov 2017  |  North America  |  Market Research

Global Biologics Market—Companies-to-Action

Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

Infographics

×

This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...